Sign Up
OverviewAPI
The Biden administration is set to reclassify marijuana from a Schedule I to a Schedule III drug, aligning federal policy with public sentiment and potentially benefiting cannabis companies. This move aims to acknowledge marijuana's therapeutic benefits and reduce penalties for use, impacting industries, taxes, and M&A activity in the sector.

Ask a question